COX-2 inhibitors - Reply

被引：2

作者：

Hawkey, CJ ^{[1
]}

机构：

[1] Univ Nottingham Hosp, Sch Med & Surg Sci, Div Gastroenterol, Nottingham NG7 2UH, England

来源：

LANCET | 1999年 / 353卷 / 9162期

关键词：

D O I：

10.1016/S0140-6736(05)75962-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1440 / 1440

页数：1

共 50 条

[1] NSAIDs: gastroprotection or selective COX-2 inhibitors? Reply
Dickman, A
Ellershaw, J
PALLIATIVE MEDICINE, 2005, 19 (02) : 166 - 167
[2] COX-2 inhibitors and risk of heart failure - Reply
Wardle, EN
LANCET, 2004, 364 (9444): : 1487 - 1487
[3] COX-2 inhibitors
Brooks, PM
Day, RO
MEDICAL JOURNAL OF AUSTRALIA, 2000, 173 (08) : 433 - 436
[4] COX-2 inhibitors
Seidenberg, BC
LANCET, 1999, 353 (9168): : 1978 - 1978
[5] COX-2 inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 1996, 1 (03) : 122 - 123
[6] COX-2 inhibitors
Becker, RC
TEXAS HEART INSTITUTE JOURNAL, 2005, 32 (03): : 380 - 383
[7] COX-2 inhibitors
Hawkey, CJ
LANCET, 1999, 353 (9149): : 307 - 314
[8] COX-2 inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 1997, 2 (09) : 393 - 393
[9] COX-2 inhibitors
Lawrie, MM
MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (07) : 367 - 367
[10] Gastrointestinal safety of NSAIDs versus COX-2 inhibitors - Reply
Drenth, Joost P. H.
van Oijen, Martijn G. H.
Verheugt, Freek W. A.
LANCET, 2007, 369 (9570): : 1345 - 1345